<DOC>
	<DOC>NCT00400309</DOC>
	<brief_summary>Primary objective: - To describe the safety profile of a Tetanus, Diphtheria, Poliomyelitis and Pertussis vaccine (REPEVAX®) when administered as a pertussis booster 1 month after a Tetanus, Diphtheria, Poliomyelitis vaccine (REVAXIS®) as compared to the safety profile of REPEVAX® administered one month after Placebo. Secondary objectives: - To describe the safety of Td-IPV vaccine (REVAXIS®) or Placebo administered to healthy adults. - To describe the safety of TdaP-IPV vaccine (REPEVAX®) administered one month after Td-IPV vaccine (REVAXIS®) or one month after Placebo.</brief_summary>
	<brief_title>Safety of REPEVAX® Given One Month After REVAXIS®</brief_title>
	<detailed_description />
	<criteria>Healthy adult, with vaccination history (by written evidence) of a minimum of 5 doses of a tetanus, diphtheria and poliomyelitis containing vaccine as recommended in the French vaccination calendar at 18 years old, and a maximum of 8 doses. Last dose of a tetanus and/or diphtheria and/or poliomyelitis containing vaccine administered either alone or in combination at least 5 years prior to the administration of the first study vaccine. Prior known hypersensitivity reaction to any diphtheria and/or tetanus and/or poliomyelitis and/or pertussis containing vaccine Any current (≤ 3 days) significant underlying disease or acute febrile illness (oral temperature ≥37.5°C) Known immunological deficiency Known malignant disease Known neurological disorder Any longterm (≥ 14 days) non steroid antiinflammatory therapy given daily within the previous 30 days Known history of severe thrombocytopenia or any coagulation disorder that would contraindicate intramuscular injection Any previous (≤ 90 days) administration of bloodderived products or immunoglobulins or scheduled to be administered through Visit 3 Any recent administration (≤ 30 days) of a vaccine or scheduled vaccination</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>40 Years</maximum_age>
	<verification_date>April 2009</verification_date>
</DOC>